Cargando…
Elevated IGF-1 with GH suppression after an oral glucose overload: incipient acromegaly or false-positive IGF-1?
OBJECTIVE: To report the evolution of patients with a suggestive clinical scenario and elevated serum insulin-like growth factor-1 (IGF-1), but growth hormone (GH) suppression in the oral glucose tolerance test (OGTT), in whom acromegaly was not initially excluded. SUBJECTS AND METHODS: Forty six pa...
Autores principales: | Rosario, Pedro W., Calsolari, Maria R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Endocrinologia e Metabologia
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522166/ https://www.ncbi.nlm.nih.gov/pubmed/27982199 http://dx.doi.org/10.1590/2359-3997000000193 |
Ejemplares similares
-
Long-term follow-up of patients with elevated IGF-1 and nadir GH > 0.4 µg/L but < 1 µg/L
por: Rosario, Pedro Weslley, et al.
Publicado: (2017) -
GH, IGF-1, and Age Are Important Contributors to Thyroid Abnormalities in Patients with Acromegaly
por: Wu, Xia, et al.
Publicado: (2018) -
Postoperative GH and Degree of Reduction in IGF-1 Predicts Postoperative Hormonal Remission in Acromegaly
por: Cardinal, Tyler, et al.
Publicado: (2021) -
Effects of combination therapy: somatostatin analogues and dopamine agonists on GH and IGF1 levels in acromegaly
por: VALEA, ANA, et al.
Publicado: (2015) -
OR16-6 Cardiometabolic Abnormalities in Patients with Acromegaly with Elevated Plasma IGF-1 Concentrations but GH Concentrations <2ng/ml
por: Hannon, Anne Marie, et al.
Publicado: (2019)